CorMedix (CRMD) Gross Margin (2013 - 2026)
CorMedix (CRMD) reported Gross Margin of 75.66% for Q2 2026, down 19.65 percentage points from 95.31% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Gross Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CorMedix's Gross Margin came in at 84.20%, down 11.42 percentage points year-over-year; for FY2025, it was 88.46%, down 4.20 percentage points from FY2024.
- Gross Margin has a five-year change of +74.09 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 92.66% in FY2024, 94.29% in FY2022 (+72.30 pp) and 22.00% in FY2021 (+7.62 pp).
- The Q2 2026 figure ranks as the lowest quarterly Gross Margin since Q2 2024.
- Year over year, Gross Margin gained in 1 of the last four quarters, with an average year-over-year change of +5.34 percentage points.
- The high point for year-over-year Gross Margin in five years was Q2 2022 (a gain of 174.56 percentage points); the low point was Q2 2026 (a drop of 19.65 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | CorMedix | 598.04 Mn | -54.48 Mn | 77.13 Mn | 75.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.66% |
| Dec 31, 2025 | 83.43% |
| Sep 30, 2025 | 89.26% |
| Jun 30, 2025 | 95.31% |
| Mar 31, 2025 | 95.91% |
| Dec 31, 2024 | 96.24% |
| Sep 30, 2024 | 94.01% |
| Jun 30, 2024 | 36.75% |
| Dec 31, 2022 | 98.63% |
| Sep 30, 2022 | 78.45% |
| Jun 30, 2022 | 98.44% |
| Mar 31, 2022 | 80.00% |
| Dec 31, 2021 | 14.88% |
| Sep 30, 2021 | 33.93% |
| Jun 30, 2021 | -76.12% |
| Mar 31, 2021 | 30.50% |
| Dec 31, 2020 | -2.72% |
| Sep 30, 2020 | 14.09% |
| Jun 30, 2020 | -16.67% |
| Mar 31, 2020 | 34.48% |
API Access
CorMedix Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();